top of page

Cervicitis

Oct 11
3 min read

Cervicitis refers to inflammation of the cervix, the ring-shaped lower part of the uterus that connects to the vagina. The condition may be acute or chronic; chronic cervicitis typically develops as a result of inadequate treatment or recurrent inflammation¹. The most common form is nonspecific cervicitis, which is not related to sexually transmitted infections such as chlamydia or gonorrhea². A single episode of acute cervicitis is most often caused by an infection such as chlamydia or gonorrhea, whereas chronic cervicitis usually results from non-infectious causes³. Untreated cervicitis can progress to pelvic inflammatory disease (PID)².

Cervicitis inflammation of the cervix
Cervicitis inflammation of the cervix

Etiology

The causes of cervicitis are divided into infectious and non-infectious categories.

  • Infectious agents include Neisseria gonorrhoeae, Chlamydia trachomatis, and less commonly herpes simplex virus, Trichomonas vaginalis, and Mycoplasma genitalium.

  • Non-infectious causes include mechanical and chemical irritants. Mechanical trauma may result from surgical instruments or foreign objects such as pessaries, condoms, diaphragms, cervical caps or tampons. Chemical irritants include soaps, detergents, spermicides, latex, vaginal douches and contraceptive creams⁴.


Epidemiology

The exact prevalence of cervicitis is difficult to determine because of the lack of a standardized definition and variation between populations. Sexual activity is the most important risk factor for infectious cervicitis, and the condition may affect approximately 30–40% of patients attending sexually transmitted infection (STI) clinics.

  • The highest prevalence is seen in sexually active women aged 15 to 24 years.

  • Cervicitis is more common in women with human immunodeficiency virus (HIV), with an estimated prevalence of 7,400 per 100,000 women diagnosed with HIV⁴.

Characteristics / Clinical Presentation

In many cases, cervicitis remains asymptomatic.

When symptoms occur, the patient may experience:

  • Vaginal discharge

  • Dyspareunia (pain during sexual intercourse)

  • Bleeding between menstrual periods

  • Bleeding after sexual intercourse¹

In rare cases, cervicitis may present in an unusual way, for example as a cervical tumor-like growth or uterovaginal prolapse, usually as a result of absent or delayed treatment¹.


Associated Comorbidities

In many cases, Mycoplasma genitalium infection occurs together with cervicitis. Gonorrhea and chlamydia are also commonly associated with cervicitis⁵⁶. If cervicitis remains untreated, it may progress to pelvic inflammatory disease (PID)⁶.


Diagnostic Tests / Laboratory Tests / Laboratory Values

To establish the diagnosis, a sample is obtained to assess for mucopurulent discharge. Testing is also performed to identify specific organisms such as Chlamydia trachomatis, Neisseria gonorrhoeae or Mycoplasma genitalium⁷.


Treatment

Treatment may be unnecessary when cervicitis is not caused by a sexually transmitted infection.

When an infection is suspected, the main goals of treatment are to eliminate the infection and prevent spread to the uterus and fallopian tubes, or to the infant during pregnancy. Depending on the causative organism, the following may be prescribed:

  • Antibiotics

  • Antifungal medication

  • Antiviral medication

Treatment of the patient's sexual partner may also be appropriate to prevent reinfection. Sexual activity should be avoided until both the patient and partner have completed treatment. Cervicitis can increase viral shedding from the cervix, which may increase the risk of transmission to a partner.

Non-pharmacological treatments such as vaginal douching or yogurt-based therapies have no documented benefit for cervicitis and may actually worsen symptoms. They are therefore not recommended⁸.


Sources:

  1. Singh N, Arora A. An Extreme Case of Chronic Cervicitis Mimicking Cervical Cancer and Causing Third-Degree Prolapse. Journal Of Gynecologic Surgery [serial online]. December 2014;30(6):380-382. : Academic Search Complete, Ipswich, MA. .

  2. Pollett S, Calderon M, Heitzinger K, Solari V, Montano S, Zunt J. Prevalence and predictors of cervicitis in female sex workers in Peru: an observational study. BMC Infectious Diseases [serial online]. April 30, 2013;13:195.: MEDLINE, Ipswich, MA.

  3. Efosa O, Uwadiegwu A. Cytopathological Examination and Epidemiological Study of Cervicitis in Commercial Sex Workers (Csws) in Coal City (Enugu), Nigeria. Ethiopian Journal Of Health Sciences [serial online]. July 2015;25(3):225-230. Academic Search Complete, Ipswich, MA.

  4. Iqbal U, Wills C. Cervicitis. . In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. :https://www.ncbi.nlm.nih.gov/books/NBK562193/

  5. Taylor S, Lensing S, Lee J, et al. Prevalence and treatment outcome of cervicitis of unknown etiology. Sexually Transmitted Diseases [serial online]. May 2013;40(5):379-385. CINAHL with Full Text, Ipswich, MA..

  6. Sheeder J, Stevens-Simon C, Lezotte D, Glazner J, Scott S. Cervicitis: To Treat or Not To Treat? The Role of Patient Preferences and Decision Analysis. Journal Of Adolescent Health [serial online]. December 2006;39(6):887-892. PsycINFO, Ipswich, MA.

  7. Lusk M, Garden F, Rawlinson W, Naing Z, Cumming R, Konecny P. Cervicitis aetiology and case definition: a study in Australian women attending sexually transmitted infection clinics. Sexually Transmitted Infections [serial online]. May 2016;92(3):175-181.: MEDLINE, Ipswich, MA.

  8. WebMD Cervicitis: https://www.webmd.com/women/guide/cervicitis

Tip: Use Ctrl + F to search on the page.

License: The original study is published under the Creative Commons Attribution 4.0 International License. This article is an independent editorial adaptation of the study’s methods and results. The wording, structure, and clinical explanations have been revised. No figures or tables from the original study have been reproduced.

https://creativecommons.org/licenses/by/4.0/

Help us keep PhysioDock free

All content on PhysioDock is free – but it costs to keep it running.

​

PhysioDock is built to be an open and accessible platform for physiotherapists, students, and patients alike. Here you’ll find articles, measurement tools, exercise libraries, diagnostic resources, and professional materials – all completely free.

Behind the scenes, however, there are hundreds of hours of work: research, writing, development, design, maintenance, testing, and updates. We do this because we believe in open knowledge and better health information.

​

If you’d like to support our work and help us continue developing and improving PhysioDock, we truly appreciate everyone who:
– subscribes to a PhysioDock+ membership
– uses and recommends PhysioDock in their work or studies
– shares PhysioDock with others

​

Every contribution makes a difference – and helps us keep the platform open to everyone.
Thank you for supporting PhysioDock!

Best value

Fysiobasen+

NOK 249

249

Every month

​

Fysiobasen+ gives you exclusive benefits such as discounts, AI tools and professional resources. Membership helps you work more efficiently, stay up to date and save time and money in your daily practice.

Valid until canceled

Access to Fysio-Open

Physionews+

Quizzes

10% discount on all purchases

5% discount on "Website for Your Clinic"

50% discount on shipping

Access to Fysiobasen AI (In Development)

Partner discounts

Exclusive product discounts

Contact us

Is something incorrect?

Something missing?
Something you’d like to see added?
More recent literature?

Feel free to get in touch and let us know which article it concerns and what could be improved.
We truly appreciate your feedback!

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Thanks for contributing!

bottom of page